GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, leveraging ...
PISCATAWAY, N.J., Aug. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, today unveiled its new global brand platform: Scripting ...
GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics ...
In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...
Although these are uncertain times, one thing I am certain of is that with synthetic biology and life sciences companies stepping in to help from all around the world, scientists like Liusong Yin may ...
PISCATAWAY, N.J., March 12, 2024 /PRNewswire/ -- On March 11, 2024, GenScript Biotech Corporation (HK.1548), a world's leading technology and service provider of life science R&D and manufacturing, ...
GenScript opens its first European mRNA production site in Delft, strengthens transatlantic biotechnology infrastructure: Delft, The Netherlands Saturday, March 14, 2026, 13:00 Hr ...
GenScript USA Inc. opened an automated gene synthesis and plasmid preparation facility in Piscataway near its U.S. headquarters on Nov. 2. The opening of the more than 50,000-square-foot facility ...
Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility expansion. DELFT, Netherlands, March 12, 2026 /PRNewswire/ -- ...
In the world of advanced medical research, the convergence of synthetic biology and cellular immunotherapy has inaugurated a new era in field of cancer treatment. Simultaneously, life science research ...
Elected officials and health care professionals are working diligently to curb the spread of monkeypox, which was declared a public health emergency earlier this month. GenScript USA Inc., a ...
GenScript’s cell therapy revenue grew by 143.7% last year as a CAR-T cell therapy developed by its Legend Biotech subsidiary gained traction. Legend Biotech continues to invest in R&D to expand the ...